2016
DOI: 10.4103/0973-029x.180938
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma

Abstract: Background:Budding uninhibited by benzimidazole related 1 (BUBR1) is an important protein in the mitotic spindle assembly checkpoint. Alterations in expression of BUBR1 have been reported in many premalignant and malignant lesions.Aim:To compare the expression of BUBR1 with respect to the normal mucosa and degree of dysplasia in oral leukoplakia (OL) and also with respect to different histopathological grades of oral squamous cell carcinoma (OSCC).Materials and Methods:Neutral buffered formalin-fixed and paraf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 19 publications
1
0
0
Order By: Relevance
“…Notably, BubR1, Mad2 and Ki-67 showed low expression in normal tissue but their expression significantly increased in the presence of dysplasia. This increasing expression was previously reported for BubR1 in oral premalignant lesions by Hsieh et al ( 18 ) and Sravya et al ( 19 ), suggesting that the deregulation of SAC is an early and important event in premalignancy. To the best of our knowledge, a significantly increased expression of Mad2 proteins, as reported in the present study, has not been described before.…”
Section: Discussionsupporting
confidence: 84%
“…Notably, BubR1, Mad2 and Ki-67 showed low expression in normal tissue but their expression significantly increased in the presence of dysplasia. This increasing expression was previously reported for BubR1 in oral premalignant lesions by Hsieh et al ( 18 ) and Sravya et al ( 19 ), suggesting that the deregulation of SAC is an early and important event in premalignancy. To the best of our knowledge, a significantly increased expression of Mad2 proteins, as reported in the present study, has not been described before.…”
Section: Discussionsupporting
confidence: 84%